Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R ...
Patients in the belantamab mafodotin arm received 2.5 mg/kg of the agent administered intravenously ... as well as in combination with novel agents and established therapies. DREAMM-8 (NCT04484623) is ...
Verdict – is the MG HS a good car? The latest MG HS represents a huge improvement over its predecessor, offering extra practicality, a nicer interior and a very competitive 75-mile range for the ...
The MG HS is offered with a conventional 1.5-litre turbocharged petrol engine lower down in the range, but there’s also a plug-in hybrid version from launch, which boasts a very competitive ...
It’s unclear whether the ES5 will be offered with more powerful motors like the MG4, which can be had with 150kW/250Nm or 180kW/350Nm, but even the standard car can hit 100km/h in 8.0sec and cruise to ...
Is the MG HS a good car? The MG HS will appeal to drivers who like getting their money’s worth, or perhaps are on a tight budget but still want a practical SUV for their next family car.
Is the MG HS a good car? The MG HS will appeal to drivers who like getting their money’s worth, or perhaps are on a tight budget but still want a practical SUV for their next family car.
Five percent of patients on one of the moderately emetogenic trials received dexamethasone ... and dolasetron (<8 h), it is not surprising that greater efficacy was noted in the delayed period ...
This is claimed to accelerate the hybrid ZS from 0-100km/h in 8.7sec. Of more relevance is its fuel consumption, and while local figures have not yet been confirmed, its European WLTP claims are ...